Physician profile
Gordon A Shields
NPI 1922059997
$2,507.24
in general payments reported to CMS, 2019-2025
17 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $41.56 · 2021: $82.01 · 2022: $183 · 2023: $417 · 2024: $602 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.94 |
| Education | $132.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $608.55 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $604.88 | 2023-2025 | Nucala |
| Genzyme Corporation | $501.25 | 2022-2025 | |
| Inspire Medical Systems, INC. | $172.79 | 2024-2025 | Inspire |
| Aerin Medical INC. | $127.77 | 2020-2024 | |
| Intersect Ent, INC. | $107.66 | 2019-2021 | |
| Amgen INC. | $61.39 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $60.40 | 2023-2025 | Ryaltris |
| Neurent Medical Limited | $50.72 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Optinose US, INC. | $48.19 | 2019-2024 | |
| Stryker Corporation | $46.79 | 2019-2021 | |
| Kaleo, INC. | $38.26 | 2022-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $17.88 | 2023 | |
| Smith+Nephew, INC. | $17.70 | 2025 | Evos, N/A, Intellio Link Werewolf |
| Ethicon US, LLC | $17.49 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $12.81 | 2021 | |
| Hologic Sales and Service, LLC | $12.71 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.